Effect of soybean protein on novel cardiovascular disease risk factors: A randomized controlled trial

C. M. Rebholz, K. Reynolds, M. R. Wofford, J. Chen, T. N. Kelly, H. Mei, P. K. Whelton, J. He

Research output: Contribution to journalArticlepeer-review

Abstract

Background/objectives: Cardiovascular disease (CVD) is the leading cause of death in the United States and the world. Clinical trials have suggested that soybean protein lowers lipids and blood pressure. The effect of soybean protein on novel CVD risk factors has not been well studied. The objective of this study was to examine the effect of soybean protein on biomarkers of inflammation, endothelial dysfunction and adipocytokines. Subjects/methods: The effect of 8 weeks of 40 g of soybean protein supplement (89.3 mg isoflavones), 40 g of milk protein supplement and 40 g of complex carbohydrate placebo was examined in a randomized, placebo-controlled, double-blind, three-phase crossover trial among adults in New Orleans, Louisiana and Jackson, Mississippi. Plasma levels of inflammation biomarkers (C-reactive protein, interleukin-6, tumor necrosis factor-α), endothelial dysfunction biomarkers (E-selectin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, thrombomodulin) and adipocytokines (high-molecular weight adiponectin, leptin, resistin) were measured at baseline and at the end of each intervention using immunoturbidimetric and enzyme-linked immunosorbent assay techniques. Results: Soy protein supplementation resulted in a significant mean net change (95% confidence interval) in plasma E-selectin of -3.93 ng/ml (-7.05 to -0.81 ng/ml; P=0.014) compared with milk protein, and in plasma leptin of -2089.8 pg/ml (-3689.3 to -490.3 pg/ml; P=0.011) compared with carbohydrate. There were no significant changes in any other risk factors. Conclusions: Soy protein supplementation may reduce levels of E-selectin and leptin. Further research is warranted to investigate the mechanisms through which protein may confer protective effects on novel CVD risk factors.

Original languageEnglish (US)
Pages (from-to)58-63
Number of pages6
JournalEuropean Journal of Clinical Nutrition
Volume67
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Keywords

  • Adipokines
  • Carbohydrates
  • Clinical trial
  • Inflammation
  • Milk proteins
  • Soybean proteins

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint

Dive into the research topics of 'Effect of soybean protein on novel cardiovascular disease risk factors: A randomized controlled trial'. Together they form a unique fingerprint.

Cite this